
Hive automates the generation and phenotyping of genetically modified model organisms to accelerate genetics-driven drug discovery. Its self-driving laboratory instruments combine automated genetic modification (including CRISPR-based editing) with high-throughput phenotyping and deep learning for image and data analysis. The platform produces transgenic animals at scale for pharmaceutical and research customers. Hive operates as a B2B supplier of laboratory instruments and services to biotech and pharmaceutical companies. Its offering targets workflows in preclinical target validation and therapeutic development.

Hive automates the generation and phenotyping of genetically modified model organisms to accelerate genetics-driven drug discovery. Its self-driving laboratory instruments combine automated genetic modification (including CRISPR-based editing) with high-throughput phenotyping and deep learning for image and data analysis. The platform produces transgenic animals at scale for pharmaceutical and research customers. Hive operates as a B2B supplier of laboratory instruments and services to biotech and pharmaceutical companies. Its offering targets workflows in preclinical target validation and therapeutic development.
What they do: Automate generation and phenotyping of genetically modified model organisms for genetics-driven drug discovery
Customers: Biotech and pharmaceutical companies (B2B instruments and services)
Founded: 2015
Industry: Biotechnology
Preclinical target validation and therapeutic development using transgenic animal models
2015
Biotechnology
Listed investor entry and last_funding_date value provided in source evidence